Skip to main content

Table 2 Laboratory parameters of study population

From: Association between serum osteocalcin and glucose/lipid metabolism in Chinese Han and Uygur populations with type 2 diabetes mellitus in Xinjiang: two cross-sectional studies

Variables

Total

Males

Females

 

Uygur

Han

P value

Uygur

Han

P value

Uygur

Han

P value

 

(n = 692)

(n = 705)

 

(n = 332)

(n = 349)

 

(n = 360)

(n = 356)

 

TOC, ng/mL

13.91 ± 7.45

19.30 ± 12.53

<0.001

12.69 ± 7.22

19.10 ± 11.71

<0.001

15.42 ± 7.46

19.60 ± 12.33

<0.001

25(OH) VD3, ng/mL

6.74 (3.62–11.23)

11.47 (6.87–18.57)

<0.001

10.61 ± 7.73

14.16 ± 9.44

0.183

7.80 ± 6.72

12.68 ± 10.21

<0.001

PTH, pg/mL

34.40 (24.15–49.30)

34.10 (23.28–48.57)

0.890

32.75 ± 19.41

34.87 ± 20.21

0.567

31.03 ± 29.87

34.66 ± 20.22

0.489

Calcium, mmol/L

2.26 ± 0.14

2.28 ± 0.17

0.927

2.16 ± 0.14

2.26 ± 0.12

0.924

2.23 ± 0.15

2.30 ± 0.12

0.875

Phosphorus, mmol/L

1.14 ± 0.21

1.11 ± 0.22

0.567

1.16 ± 0.22

1.08 ± 1.23

0.395

1.15 ± 1.29

1.14 ± 0.20

0.780

ALP, U/L

88.31 ± 27.22

70.75 ± 21.21

<0.001

81.16 ± 23.78

67.37 ± 19.16

0.242

94.44 ± 28.52

74.98 ± 22.91

<0.001

hs-CRP, mg/L

3.35 (1.63–6.45)

1.62 (0.86–3.78)

<0.001

2.73 (1.30–5.20)

1.60 (0.74–1.32)

0.001

4.24 (2.17–7.78)

1.46 (0.83 ~ 3.70)

<0.001

Creatinine, μmol/L

62.25 ± 21.62

71.17 ± 23.56

<0.001

75.17 ± 22.22

77.59 ± 22.46

0.596

56.98 ± 17.23

62.92 ± 22.39

<0.001

FPG, mmol/L

9.58 ± 3.70

8.18 ± 3.39

<0.001

9.22 ± 3.34

8.30 ± 3.45

0.013

9.87 ± 3.95

8.02 ± 3.31

<0.001

2 h–PG, mmol/L

18.23 ± 5.81

16.86 ± 6.52

<0.001

22.80 ± 9.50

17.49 ± 5.90

0.006

18.83 ± 5.67

16.33 ± 6.64

<0.001

FINS, mU/L

9.05 (5.30–14.77)

7.49 (5.02–11.4)

0.230

8.17 ± 7.63

7.81 ± 7.29

0.115

4.13 ± 3.44

5.12 ± 3.85

0.424

FCP, ng/mL

2.33 ± 1.13

2.34 ± 1.26

0.217

1.86 ± 1.32

1.79 ± 1.54

0.480

1.85 ± 1.39

1.88 ± 1.54

0.394

2 h–CP, ng/mL

5.14 ± 2.84

5.86 ± 3.20

<0.001

4.22 ± 3.03

4.43 ± 3.52

1.620

4.13 ± 3.44

5.12 ± 3.85

0.001

HbA1C, %

9.56 ± 2.11

8.49 ± 2.07

<0.001

9.48 ± 2.14

8.60 ± 2.14

0.021

9.62 ± 2.07

8.51 ± 3.71

<0.001

TC, mmol/L

4.84 ± 1.34

4.47 ± 1.15

<0.001

4.76 ± 1.43

4.36 ± 1.21

0.578

4.89 ± 1.25

4.60 ± 1.06

0.002

TG, mmol/L

2.24 ± 1.77

2.02 ± 1.68

0.018

1.93 (1.38–3.25)

1.69 (1.38–2.25)

0.187

1.80 (1.32–3.35)

1.60 (1.21–2.27)

0.031

LDL-C, mmol/L

2.90 ± 1.00

2.60 ± 0.88

<0.001

2.80 ± 0.99

2.54 ± 0.90

0.759

2.99 ± 1.00

2.67 ± 0.85

<0.001

HDL-C, mmol/L

1.65 ± 0.78

1.69 ± 1.14

0.334

1.62 ± 0.96

1.66 ± 1.05

0.334

1.67 ± 0.59

1.72 ± 1.23

0.357

P1NP, ng/mL

49.29 ± 28.33

46.24 ± 21.96

0.345

43.35 ± 13.36

47.87 ± 21.57

0.750

54.00 ± 33.07

41.87 ± 21.57

0.275

β-CTX, ng/mL

0.46 ± 0.27

0.41 ± 0.20

0.043

0.41 ± 0.21

0.38 ± 0.20

0.081

0.50 ± 0.31

0.40 ± 0.21

0.012

HOMA-IR

3.72 (2.07–5.07)

2.48 (0.15–4.17)

0.410

2.71 (1.16–4.92)

2.02 (1.38–4.20)

0.205

3.52 (1.60–5.66)

2.67 (1.60–3.90)

0.501

HOMA-IS

0.37 (0.18–0.48)

0.41 (0.24–0.69)

0.137

0.37 (0.20–0.86)

0.49 (0.24–0.73)

0.126

0.28 (0.18–0.63)

0.28 (0.26–0.63)

0.083

HOMA-β, %

39.59 (17.33–78.82)

45.41 (21.98–87.72)

0.561

29.74 (10.21–59.62)

38.30 (19.11–72.48)

0.213

38.42 (14.16–79.91)

54.23 (31.14–101.32)

0.337

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X